Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLINATUMOMAB Cause Nervous system disorder? 147 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Nervous system disorder have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 1.6% of all adverse event reports for BLINATUMOMAB.

147
Reports of Nervous system disorder with BLINATUMOMAB
1.6%
of all BLINATUMOMAB reports
19
Deaths
69
Hospitalizations

How Dangerous Is Nervous system disorder From BLINATUMOMAB?

Of the 147 reports, 19 (12.9%) resulted in death, 69 (46.9%) required hospitalization, and 15 (10.2%) were considered life-threatening.

Is Nervous system disorder Listed in the Official Label?

Yes, Nervous system disorder is listed as a known adverse reaction in the official FDA drug label for BLINATUMOMAB.

What Other Side Effects Does BLINATUMOMAB Cause?

Pyrexia (1,064) Acute lymphocytic leukaemia recurrent (977) Cytokine release syndrome (952) Off label use (590) Death (588) Neurotoxicity (530) Drug ineffective (345) Headache (335) Neutropenia (265) Febrile neutropenia (262)

What Other Drugs Cause Nervous system disorder?

ADALIMUMAB (653) METHOTREXATE (489) CIPROFLOXACIN (449) ACETAMINOPHEN\PROPOXYPHENE (399) PROPOXYPHENE (399) RITUXIMAB (389) ETANERCEPT (361) CYCLOPHOSPHAMIDE (357) DEXAMETHASONE (346) LEVOFLOXACIN (323)

Which BLINATUMOMAB Alternatives Have Lower Nervous system disorder Risk?

BLINATUMOMAB vs BLONANSERIN BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLINATUMOMAB vs BOCEPREVIR BLINATUMOMAB vs BOCOCIZUMAB BLINATUMOMAB vs BONIVA

Related Pages

BLINATUMOMAB Full Profile All Nervous system disorder Reports All Drugs Causing Nervous system disorder BLINATUMOMAB Demographics